References
- Arber CE, Li A, Houlden H et al., Review: insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories. Neuropathol Appl Neurobiol. 2016;42:220–241.
- Gregory A, Polster BJ, Hayflick SJ. Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet. 2009;46:73–80.
- Zhou B, Westaway SK, Levinson B et al., A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet. 2001;28:345–349.
- Hayflick SJ, Westaway SK, Levinson B et al., Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med. 2003;348:33–40.
- Mak CM, Sheng B, Lee HH et al., Young-onset parkinsonism in a Hong Kong Chinese man with adult-onset Hallervorden-Spatz syndrome. Int J Neurosci. 2011;121:224–227.
- Li YF, Li HF, Zhang YB et al., Novel homozygous PANK2 mutation identified in a consanguineous Chinese pedigree with pantothenate kinase-associated neurodegeneration. Biomed Rep. 2016;5:217–220.
- Wu YR, Chen CM, Chao CY et al., Pantothenate kinase-associated neurodegeneration in two Taiwanese siblings: identification of a novel PANK2 gene mutation. Mov Disord. 2009;24:940–941.
- Zhang YH, Tang BS, Zhao AL et al., Novel compound heterozygous mutations in the PANK2 gene in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration. Mov Disord. 2005;20:819–821.
- Swaiman KF. Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol. 1991;48:1285–1293.
- Swaiman KF. Hallervorden-Spatz syndrome. Pediatr Neurol. 2001;25:102–108.
- Lee CH, Lu CS, Chuang WL et al., Phenotypes and genotypes of patients with pantothenate kinase-associated neurodegeneration in Asian and Caucasian populations: 2 cases and literature review. Sci World J. 2013;2013:860539.
- Kruer MC, Boddaert N. Neurodegeneration with brain iron accumulation: a diagnostic algorithm. Semin Pediatr Neurol. 2012;19;67–74.
- Srinivasan KG, Praveen Kumar M, Ushanandhini KP et al., MRI eye-of-the-tiger sign in organophosphate poisoning. A case report. Neuroradiol J. 2010;23:407–411.
- Davie CA, Barker GJ, Machado C et al., Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome. Mov Disord. 1997;12:767–771.
- Molinuevo JL, Munoz E, Valldeoriola F et al., The eye of the tiger sign in cortical-basal ganglionic degeneration. Mov Disord. 1999;14:169–171.
- Strecker K, Hesse S, Wegner F et al., Eye of the tiger sign in multiple system atrophy. Eur J Neurol. 2007;14:e1–e2.
- Han J, Kim W, Lee CH et al., Optic atrophy in a patient with atypical pantothenate kinase-associated neurodegeneration. J Neuroophthalmol. 2016;36:182–186.
- Mahoui S, Benhaddadi A, Ameur El Khedoud W et al., Atypical pantothenate kinase-associated neurodegeneration: clinical description of two brothers and a review of the literature. Rev Neurol (Paris). 2017;173:658–662.